Cargando…

SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells

BACKGROUND: Patients undergoing immune modulatory therapies for the treatment of autoimmune diseases such as multiple sclerosis, and individuals with an impaired-immune system, most notably AIDS patients, are in the high risk group of developing progressive multifocal leukoencephalopathy (PML), a fa...

Descripción completa

Detalles Bibliográficos
Autores principales: Uleri, Elena, Regan, Patrick, Dolei, Antonina, Sariyer, Ilker Kudret
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2013
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671132/
https://www.ncbi.nlm.nih.gov/pubmed/23672192
http://dx.doi.org/10.1186/1743-422X-10-147
_version_ 1782271929776865280
author Uleri, Elena
Regan, Patrick
Dolei, Antonina
Sariyer, Ilker Kudret
author_facet Uleri, Elena
Regan, Patrick
Dolei, Antonina
Sariyer, Ilker Kudret
author_sort Uleri, Elena
collection PubMed
description BACKGROUND: Patients undergoing immune modulatory therapies for the treatment of autoimmune diseases such as multiple sclerosis, and individuals with an impaired-immune system, most notably AIDS patients, are in the high risk group of developing progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the white matter caused by human neurotropic polyomavirus, JC virus. It is now widely accepted that pathologic strains of JCV shows unique rearrangements consist of deletions and insertions within viral NCCR. While these kinds of rearrangements are related to viral tropism and pathology of the disease, their roles in molecular regulation of JCV gene expression and replication are unclear. We have previously identified SF2/ASF as a negative regulator of JCV gene expression in glial cells. This negative impact of SF2/ASF was dependent on its ability to bind a specific region mapped to the tandem repeat within viral promoter. In this report, functional role of SF2/ASF binding region in viral gene expression and replication was investigated by using deletion mutants of viral regulatory sequences. RESULTS: The second 98-base-pair tandem repeat on Mad1 strain was first mutated by deletion and named Mad1-(1X98). In addition to this mutant, the CR3 region which served the binding side for SF2/ASF was also mutated and named Mad1-ΔCR3 (1X73). Both mutations were tested for SF2/ASF binding by ChIP assay. While SF2/ASF was associated with Mad1-WT and Mad1-(1X98), its interaction was completely abolished on Mad1-ΔCR3 (1X73) construct as expected. Surprisingly, reporter gene analysis of Mad1-(1X98) and Mad1-ΔCR3 (1X73) early promoter sequences showed two and three fold increase in promoter activities, respectively. The impact of “CR3” region on JCV propagation was also tested on the viral background. While replication of Mad1-(1X98) strain in glial cells was similar to Mad1-WT strain, propagation of Mad1-ΔCR3 (1X73) was less productive. Further analysis of the transcription mediated by Mad1-ΔCR3 (1X73) NCCR revealed that late gene expression was significantly affected. CONCLUSIONS: The results of this study reveal a differential role of CR3 region within JCV NCCR in expression of JCV early and late genes.
format Online
Article
Text
id pubmed-3671132
institution National Center for Biotechnology Information
language English
publishDate 2013
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-36711322013-06-05 SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells Uleri, Elena Regan, Patrick Dolei, Antonina Sariyer, Ilker Kudret Virol J Research BACKGROUND: Patients undergoing immune modulatory therapies for the treatment of autoimmune diseases such as multiple sclerosis, and individuals with an impaired-immune system, most notably AIDS patients, are in the high risk group of developing progressive multifocal leukoencephalopathy (PML), a fatal demyelinating disease of the white matter caused by human neurotropic polyomavirus, JC virus. It is now widely accepted that pathologic strains of JCV shows unique rearrangements consist of deletions and insertions within viral NCCR. While these kinds of rearrangements are related to viral tropism and pathology of the disease, their roles in molecular regulation of JCV gene expression and replication are unclear. We have previously identified SF2/ASF as a negative regulator of JCV gene expression in glial cells. This negative impact of SF2/ASF was dependent on its ability to bind a specific region mapped to the tandem repeat within viral promoter. In this report, functional role of SF2/ASF binding region in viral gene expression and replication was investigated by using deletion mutants of viral regulatory sequences. RESULTS: The second 98-base-pair tandem repeat on Mad1 strain was first mutated by deletion and named Mad1-(1X98). In addition to this mutant, the CR3 region which served the binding side for SF2/ASF was also mutated and named Mad1-ΔCR3 (1X73). Both mutations were tested for SF2/ASF binding by ChIP assay. While SF2/ASF was associated with Mad1-WT and Mad1-(1X98), its interaction was completely abolished on Mad1-ΔCR3 (1X73) construct as expected. Surprisingly, reporter gene analysis of Mad1-(1X98) and Mad1-ΔCR3 (1X73) early promoter sequences showed two and three fold increase in promoter activities, respectively. The impact of “CR3” region on JCV propagation was also tested on the viral background. While replication of Mad1-(1X98) strain in glial cells was similar to Mad1-WT strain, propagation of Mad1-ΔCR3 (1X73) was less productive. Further analysis of the transcription mediated by Mad1-ΔCR3 (1X73) NCCR revealed that late gene expression was significantly affected. CONCLUSIONS: The results of this study reveal a differential role of CR3 region within JCV NCCR in expression of JCV early and late genes. BioMed Central 2013-05-14 /pmc/articles/PMC3671132/ /pubmed/23672192 http://dx.doi.org/10.1186/1743-422X-10-147 Text en Copyright © 2013 Uleri et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research
Uleri, Elena
Regan, Patrick
Dolei, Antonina
Sariyer, Ilker Kudret
SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells
title SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells
title_full SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells
title_fullStr SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells
title_full_unstemmed SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells
title_short SF2/ASF binding region within JC virus NCCR limits early gene transcription in glial cells
title_sort sf2/asf binding region within jc virus nccr limits early gene transcription in glial cells
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3671132/
https://www.ncbi.nlm.nih.gov/pubmed/23672192
http://dx.doi.org/10.1186/1743-422X-10-147
work_keys_str_mv AT ulerielena sf2asfbindingregionwithinjcvirusnccrlimitsearlygenetranscriptioninglialcells
AT reganpatrick sf2asfbindingregionwithinjcvirusnccrlimitsearlygenetranscriptioninglialcells
AT doleiantonina sf2asfbindingregionwithinjcvirusnccrlimitsearlygenetranscriptioninglialcells
AT sariyerilkerkudret sf2asfbindingregionwithinjcvirusnccrlimitsearlygenetranscriptioninglialcells